Block, Siteadmin, SkipCaptcha, Upload, Automoderated users, delete, edit, move, nsTeam2RO, nsTeam2RW, nsTeam2_talkRO, nsTeam2_talkRW, protect, rollback, Administrators, template
293,634
edits
Changes
Jump to navigation
Jump to search
Line 29:
Line 29: − +
Pfizer COVID vaccine (view source)
Revision as of 07:54, December 15, 2021
, 07:54, December 15, 2021→FDA requests 75 years to comply
===FDA requests 75 years to comply===
===FDA requests 75 years to comply===
The U.S. [[Food & Drug Administration]] (FDA) asked for 75 years to fully release redacted versions of all documents related to the FDA'sa approval of Pfizer’s Comirnaty COVID-19 vaccine. This would mean the entire cache of documents would not be fully released until 2096. The FDA’s initial timeline would have meant the release of the documents would not be completed until 2076, or 55 years from now.
The U.S. [[Food and Drug Administration]] (FDA) asked for 75 years to fully release redacted versions of all documents related to the FDA'sa approval of Pfizer’s Comirnaty COVID-19 vaccine. This would mean the entire cache of documents would not be fully released until 2096. The FDA’s initial timeline would have meant the release of the documents would not be completed until 2076, or 55 years from now.
In a filing submitted to a federal judge in November 2021, the Biden [[Department of Justice]] (DOJ), arguing on behalf of the FDA, initially claimed the agency could process some 329,000 pages of documents at a rate of only 500 pages per month, in order to have time to redact legally exempt material. According to the DOJ, such material includes “confidential business and trade secret information of Pfizer or BioNTech and personal privacy information of patients who participated in clinical trials.”
In a filing submitted to a federal judge in November 2021, the Biden [[Department of Justice]] (DOJ), arguing on behalf of the FDA, initially claimed the agency could process some 329,000 pages of documents at a rate of only 500 pages per month, in order to have time to redact legally exempt material. According to the DOJ, such material includes “confidential business and trade secret information of Pfizer or BioNTech and personal privacy information of patients who participated in clinical trials.”